Ocugen, Inc.
DE ˙ DB ˙ US67577C1053
1,15 € ↑0,02 (2,13%)
2026-06-05
DEL PRIS
SecurityDE:2H51 / Ocugen, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership713,736 shares
Latest Disclosed Value $ 1,291,862
Northern Trust Corp reports 7.13% increase in ownership of 2H51 / Ocugen, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 713,736 shares of Ocugen, Inc. (DE:2H51) valued at $1,118,424 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 666,237 shares of Ocugen, Inc.. This represents a change in shares of 7.13% during the quarter. The current value of the position is $820,796 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F OCUGEN COM 67577C105 713,736 47,499 7.13 1,292 43.60 0.0000
2026-02-17 2025-12-31 13F OCUGEN COM 67577C105 666,237 69,689 11.68 899 -7.51 0.0001
2025-11-14 2025-09-30 13F OCUGEN COM 67577C105 596,548 30,543 5.40 972 77.05 0.0001
2025-08-13 2025-06-30 13F OCUGEN COM 67577C105 566,005 -1,783,423 -75.91 549 -66.91 0.0001
2025-05-13 2025-03-31 13F OCUGEN COM 67577C105 2,349,428 -57,709 -2.40 1,659 -14.35 0.0002
2025-02-14 2024-12-31 13F OCUGEN COM 67577C105 2,407,137 227,150 10.42 1,938 -10.41 0.0003
2024-11-13 2024-09-30 13F OCUGEN COM 67577C105 2,179,987 1,555,980 249.35 2,163 123.58 0.0004
2024-08-14 2024-06-30 13F OCUGEN COM 67577C105 624,007 114,690 22.52 967 15.81 0.0002
2024-05-14 2024-03-31 13F OCUGEN COM 67577C105 509,317 -432 -0.08 835 184.98 0.0001
2024-02-13 2023-12-31 13F OCUGEN COM 67577C105 509,749 64,796 14.56 293 65.54 0.0001
2023-11-13 2023-09-30 13F OCUGEN COM 67577C105 444,953 55,113 14.14 178 -16.11 0.0000
2023-08-11 2023-06-30 13F OCUGEN COM 67577C105 389,840 -1,423,292 -78.50 212 -86.35 0.0000
2023-05-15 2023-03-31 13F OCUGEN COM 67577C105 1,813,132 -65,682 -3.50 1,547 -36.69 0.0003
2023-02-13 2022-12-31 13F OCUGEN COM 67577C105 1,878,814 -123,907 -6.19 2,442 -31.52 0.0005
2022-11-14 2022-09-30 13F OCUGEN COM 67577C105 2,002,721 -24,047 -1.19 3,566 -22.48 0.0008
2022-08-12 2022-06-30 13F OCUGEN COM 67577C105 2,026,768 262,677 14.89 4,600 -20.98 0.0010
2022-05-13 2022-03-31 13F OCUGEN COM 67577C105 1,764,091 -77,645 -4.22 5,821 -30.54 0.0010
2022-02-08 2021-12-31 13F OCUGEN COM 67577C105 1,841,736 -7,055 -0.38 8,380 -36.87 0.0014
2021-11-15 2021-09-30 13F OCUGEN COM 67577C105 1,848,791 -61,710 -3.23 13,275 -13.47 0.0023
2021-08-13 2021-06-30 13F OCUGEN COM 67577C105 1,910,501 1,551,299 431.87 15,341 528.99 0.0027
2021-05-12 2021-03-31 13F OCUGEN COM 67577C105 359,202 53,084 17.34 2,439 335.54 0.0005
2021-02-11 2020-12-31 13F OCUGEN COM 67577C105 306,118 169,454 123.99 560 1,233.33 0.0001
2020-11-16 2020-09-30 13F OCUGEN COM 67577C105 136,664 96,202 237.76 42 366.67 0.0000
2020-08-14 2020-06-30 13F OCUGEN COM 67577C105 40,462 -1,542 -3.67 9 -25.00 0.0000
2020-05-14 2020-03-31 13F OCUGEN COM 67577C105 42,004 42,004 3.81 12 33.33 0.0000
2019-11-13 2019-09-30 13F HISTOGENICS COM 43358V109 0 -20,240 -100.00 0 -100.00
2019-08-13 2019-06-30 13F HISTOGENICS COM 43358V109 20,240 0 0.00 4 100.00 0.0000
2019-05-13 2019-03-31 13F HISTOGENICS COM 43358V109 20,240 0 0.00 2 0.00 0.0000
2019-02-12 2018-12-31 13F HISTOGENICS COM 43358V109 20,240 0 0.00 2 -81.82 0.0000
2018-11-14 2018-09-30 13F HISTOGENICS COM 43358V109 20,240 0 0.00 11 -78.43 0.0000
2018-09-18 2018-06-30 13F/A-1 HISTOGENICS COM 43358V109 20,240 4,780 30.92 51 18.60 0.0000
2018-08-14 2018-06-30 13F HISTOGENICS COM 43358V109 20,240 4,780 51
2018-05-09 2018-03-31 13F HISTOGENICS COM 43358V109 15,460 15,460 43 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.